Actively Recruiting
Phase I Trial to Assess Safety and Processing of LG-0317 in Healthy Adults Aged 18 to 45
Led by LinGang Laboratory · Updated on 2026-06-25
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating LG-0317, a new drug, in healthy adults aged 18 to 45 to assess its safety, tolerability, and how the body processes it. This first administration of LG-0317 to humans aims to gather key information to support future studies exploring the drugs effects. The study is a Phase I clinical trial designed for healthy volunteers to carefully monitor initial reactions and drug behavior. The trial has three parts single ascending dose, food effect, and multiple ascending dose. In the single ascending dose part, participants undergo a screening period of 4 weeks, followed by dosing and observation, then a follow-up period. In the food effect part, participants receive one dose of LG-0317 either fasting or after a high-fat meal, assigned by random sequence. The multiple ascending dose part involves 3 to 4 dose groups with doses chosen based on earlier safety and pharmacokinetic data. Participants may receive LG-0317 or placebo tablets during these parts. Participants will be closely monitored for safety through assessments including vital signs, physical exams, blood tests, ECGs, and adverse event tracking from day 1 to day 18. Researchers measure adverse events, lab abnormalities, vital sign changes, and ECG findings to evaluate tolerability. The trial includes randomized assignment and triple masking to maintain study integrity. Total participation lasts through the dosing and follow-up periods, with detailed safety and pharmacokinetic data collection.
CONDITIONS
Brief Title
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
Research Team
T
Translational Clinical Group officer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here